Criteria for use of sargramostim (granulocyte-macrophage colony-stimulating factor).
D001855:Bone Marrow Diseases / Q000188:drug therapy; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans
D016178:Granulocyte-Macrophage Colony-Stimulating Factor